Use of Metformin Versus Chromium Picolinate in the Management of Polycystic Ovarian Syndrome: A Randomized Controlled Clinical Trial

    June 2019 in “ The Egyptian Journal of Fertility and Sterility ”
    Eman Ahmed Kishk, Rasha Imam Farhan, Mohamed Fawzy Shalaan, Magda Moustafa El-Beialy
    Studysummary This study found that while there were no significant differences in ovulation and pregnancy rates, chromium picolinate was better tolerated than metformin in women with polycystic ovarian syndrome.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on egyfs.journals.ekb.eg →
    Discuss this study in the Community →

    Related research 2

    1. Metformin Therapy for the Reproductive and Metabolic Consequences of Polycystic Ovary Syndrome Diabetologia · 2017
    2. Metformin: An Old Medication of New Fashion: Evolving New Molecular Mechanisms and Clinical Implications in Polycystic Ovary Syndrome European journal of endocrinology · 2009